Jupiter Asset Management’s Haemonetics HAE Stock Holding History

Jupiter Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.23M	Sell	69,724 -45,370	-39%	-$2.91M	0.03%	360
2026 Q1	$6.49M	Buy	+115,094	New	+$7.5M	0.03%	324
2024 Q2	–	Sell	-2,445	Closed	-$209K	–	423
2024 Q1	$209K	Sell	2,445 -9,095	-79%	-$714K	﹤0.01%	417
2023 Q4	$987K	Sell	11,540 -84	-0.7%	-$7.26K	0.01%	381
2023 Q3	$1.04M	Buy	11,624 +1,274	+12%	+$114K	0.01%	397
2023 Q2	$881K	Hold	10,350	–	–	0.01%	438
2023 Q1	$856K	Buy	10,350 +1,460	+16%	+$118K	0.01%	351
2022 Q4	$699K	Buy	+8,890	New	+$715K	0.01%	393

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Asset Management's HAE Position: Q2 2026 in Review

Jupiter Asset Management reduced its Haemonetics (HAE) stake by 39% in Q2 2026, selling an estimated $2.91M and leaving 69,724 shares worth $5.23M. The position accounts for 0.03% of the portfolio, ranked #360.

Jupiter Asset Management first reported a position in HAE in Q4 2022 and has held it in 8 quarters since. The position peaked at $6.49M in Q1 2026. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Jupiter Asset Management held 69,724 shares of Haemonetics worth $5.23M as of Q2 2026.
Jupiter Asset Management sold 45,370 Haemonetics shares in Q2 2026, an estimated $2.91M.
Haemonetics made up 0.03% of Jupiter Asset Management's portfolio in Q2 2026, its #360 holding.
Jupiter Asset Management first reported a position in Haemonetics in Q4 2022 and has held it in 8 quarters since.
Jupiter Asset Management's Haemonetics position peaked at $6.49M in Q1 2026.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.